Altimmune
ALT
$7.30
Share price
1.53%
Change (1 day)
46.59%
Change (1 year)
Categories
EPS for Altimmune (ALT)
EPS in 2023 (TTM): -$1.63
According to Altimmune's latest financial reports the company's current EPS (TTM) is -$1.63. In 2022 the company made an earnings per share (EPS) of -$1.77 an increase over its 2021 EPS that were of -$2.36.
EPS history for Altimmune from 2006 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.63 | -7.91% |
| 2022 | -$1.77 | -25% |
| 2021 | -$2.36 | 23.56% |
| 2020 | -$1.91 | 25.66% |
| 2019 | -$1.52 | -93.18% |
| 2018 | -$22.30 | -78.95% |
| 2017 | -$105.92 | 117.94% |
| 2016 | -$48.60 | 170% |
| 2015 | -$18.00 | -64.71% |
| 2014 | -$51.00 | -22.73% |
| 2013 | -$66.00 | 110.68% |
| 2012 | -$31.33 | 49.18% |
| 2011 | -$21.00 | -93.64% |
| 2010 | -$330.00 | -5.98% |
| 2009 | -$351.00 | -26.88% |
| 2008 | -$480.00 | -79.61% |
| 2007 | -$2,354 | -61.5% |
| 2006 | -$6,114 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -$0.27 | -83.44% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -$1.00 | -38.65% | 🇺🇸 USA |